Comparing biologicals for severe chronic rhinosinusitis with nasal polyps: A network meta-analysis
Allergy
.
2022 Apr;77(4):1299-1306.
doi: 10.1111/all.15205.
Epub 2022 Jan 12.
Authors
José Laerte Boechat
1
2
3
,
Diana Silva
2
4
,
Bernardo Sousa-Pinto
3
5
,
Luís Delgado
2
3
4
Affiliations
1
Clinical Immunology Service, Internal Medicine Department, Faculty of Medicine, Fluminense Federal University, Niteroi, Brazil.
2
Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
3
Center for Health Technology and Services Research (CINTESIS@RISE), Faculty of Medicine, University of Porto, Porto, Portugal.
4
Serviço de Imunoalergologia, Centro Hospitalar de São João, E.P.E., Porto, Portugal.
5
MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
PMID:
34981835
DOI:
10.1111/all.15205
No abstract available
Publication types
Letter
Comment
MeSH terms
Biological Products* / therapeutic use
Chronic Disease
Humans
Nasal Polyps* / complications
Nasal Polyps* / drug therapy
Network Meta-Analysis
Rhinitis* / drug therapy
Sinusitis* / drug therapy
Substances
Biological Products